Mount Sinai Launches Novel Technology Fund
by Mount Sinai Innovation Partners (MSIP), which is the business or department of commercialization of the Mount Sinai Health System in New York, announced the debut …
Cigna Announces Services to Improve Health Outcomes of Complex Cancer Patients
by Patients and their community oncologists are connected to cancer subspecialty experts at National Cancer Institute through a new health service program, which is run by …
Oppo Ventures in Healthcare Innovations Spurred by Accelerator Grants
Oppo is exploring potential healthcare innovations to help commercialize and integrate into its products. The Chinese smartphone manufacturer will contribute $460,000 to ideas that address …
Ways in Which COVID-19 Transformed Healthcare IT
Healthcare IT is a massive industry and is slated to register exponential growth worldwide. The unprecedented outbreak of the COVID-19, which also lasted for two …
USFDA Approves Lupin’s Generic Equivalent to Pregabalin Capsules
by A recent announcement by Mumbai based drug manufacturer, Lupin states that they have bagged approval from USFDA – the United States Food and Drug Administration, …
Pharmaceutical Innovations Contribute Towards Job Push in Europe
by The pharmaceutical sector in the European Union is a solid industry, accounting for €118 billion external trade surplus in the EU. It also gives direct …
IIT Madras Research Park to Host Pfizer’s Launch of Global Drug Development Centre
Pfizer, which developed the mRNA-based vaccination against the novel coronavirus, announced the establishment of a worldwide drug development center in India to facilitate advanced research …
Pharmaceutical Manufacturers Navigating Muddy Water of ESG Requirements
The pharmaceutical sector is undergoing a transition as focus on sustainability becomes the number one priority worldwide. Corporate responsibility has never been more relevant than …
Will Pharmaceutical Counterfeiting Continue Posing Threat to EU?
Latest reports by Europol suggest that European Union (EU) is yet to over the threat posed by pharmaceutical counterfeit. Substandard and counterfeit drugs have been …